| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jun―20 |
Impact of COVID-19 on the management of hypertension: a perspective on disease severity, service use patterns and expenditures from Ghana’s health insurance claims data |
Ama Pokuaa Fenny, Evans Otieku, Samuel Owusu Achiaw, Bernard Okoe Boye, Francis Asenso-Boadi, Vivian Addo-Cobbiah, Mariam Musah |
| 2 |
[GO] |
2022―Jul―18 |
The influence of the pandemic on fear of contagion, blood pressure management and adherence to medication in hypertensive older adults in Turkey |
Ayşegül Özcan, İlknur Aydın Avcı |
| 3 |
[GO] |
2022―Jul―05 |
The effects of antihypertensive medications on severity and outcomes of hypertensive patients with COVID-19 |
Samira Nakhaie, Rostam Yazdani, Mohammadreza Shakibi, Soheila Torabian, Sara Pezeshki, Maliheh Sadat Bazrafshani, Maryam Azimi, Faranak Salajegheh |
| 4 |
[GO] |
2021―Nov―12 |
Bioengineered angiotensin-converting-enzyme-2: a potential therapeutic option against SARS-CoV-2 infection |
Biplab K. Maiti |
| 5 |
[GO] |
2021―Sep―10 |
Resistant hypertension and COVID-19: tip of the iceberg? |
Marijana Tadic, Cesare Cuspidi |
| 6 |
[GO] |
2021―Aug―05 |
The effect of resistant hypertension on in-hospital mortality in patients hospitalized with COVID-19 |
Ferhat Işık, Murat Çap, Abdurrahman Akyüz, Önder Bilge, Burhan Aslan, Ümit İnci, İlyas Kaya, Ercan Taştan, Metin Okşul, Neşe Kanbal Çap, Ali Karagöz, Erkan Baysal |
| 7 |
[GO] |
2021―Jan―22 |
COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society |
Christopher E. Clark, Sinead T. J. McDonagh, Richard J. McManus, Una Martin |
| 8 |
[GO] |
2020―Dec―14 |
A historical perspective on ACE2 in the COVID-19 era |
Vivek Bhalla, Catherine A. Blish, Andrew M. South |
| 9 |
[GO] |
2020―Dec―10 |
A small contribution to mitigate the collision of transmissible and chronic diseases, exemplified by the management of hypertension during the COVID-19 pandemic |
Gloria Valdés, Carlos Zúñiga |
| 10 |
[GO] |
2020―Nov―09 |
The outcomes of the postulated interaction between SARS-CoV-2 and the renin-angiotensin system on the clinician’s attitudes toward hypertension treatment |
Cenk Sarı, Ersin Çağrı Şimşek, Öner Özdoğan |
| 11 |
[GO] |
2020―Sep―17 |
Promising effects of exercise on the cardiovascular, metabolic and immune system during COVID-19 period |
Isley Jesus, Valentin Vanhee, Therese B. Deramaudt, Marcel Bonay |
| 12 |
[GO] |
2020―Aug―24 |
Association between renin-angiotensin-aldosterone system inhibitor treatment, neutrophil-lymphocyte ratio, D-Dimer and clinical severity of COVID-19 in hospitalized patients: a multicenter, observational study |
Selcuk Gormez, Erkan Ekicibasi, Aleks Degirmencioglu, Ashok Paudel, Refik Erdim, Hilal Kurtoglu Gumusel, Elif Eroglu, Ibrahim Halil Tanboga, Sinan Dagdelen, Nevin Sariguzel, Ceyda Erel Kirisoglu, Burak Pamukcu |
| 13 |
[GO] |
2020―Aug―13 |
Vitamin D deficiency in African Americans is associated with a high risk of severe disease and mortality by SARS-CoV-2 |
Virna Margarita Martín Giménez, Felipe Inserra, León Ferder, Joxel García, Walter Manucha |
| 14 |
[GO] |
2020―Jul―27 |
Covid-19 and the cardiovascular system: a comprehensive review |
Rafael Bellotti Azevedo, Bruna Gopp Botelho, João Victor Gonçalves de Hollanda, Leonardo Villa Leão Ferreira, Letícia Zarur Junqueira de Andrade, Stephanie Si Min Lilienwald Oei, Tomás de Souza Mello, Elizabeth Silaid Muxfeldt |
| 15 |
[GO] |
2020―May―14 |
Managing hypertension during the COVID-19 pandemic |
Sunil K. Nadar, Muzahir H. Tayebjee, Michael Stowasser, James Brian Byrd |
